Cited by 106Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesHair Growth and Disorders

Pharmacotherapy for trichotillomania

Open access
Rothbart, Rachel, Amos, Taryn, Siegfried, Nandi, Ipser, Jonathan C, Fineberg, Naomi, Chamberlain, Samuel R, Stein, Dan J·2013·Cochrane Database of Systematic Reviews

Abstract

Background Trichotillomania (TTM) (hair-pulling disorder) is a prevalent and disabling disorder characterised by recurrent hair-pulling. The effect of medication on trichotillomania has not been systematically evaluated. Objectives To assess the effects of medication for trichotillomania in adults compared with placebo or other active agents. Search methods We searched the Cochrane Central Register of Controlled Trials and the Cochrane Depression, Anxiety and Neurosis Group Register (to 31 July 2013), which includes relevant randomised controlled trials from the following bibliographic databases: The Cochrane Library (all years); EMBASE (1974 to date); MEDLINE (1950 to date) and PsycINFO (1967 to date). Two review authors identified relevant trials by assessing the abstracts of all possible studies. Selection criteria We selected randomised controlled trials (RCTs) of a medication versus placebo or active agent for TTM in adults. Data collection and analysis Two review authors independently performed the data extraction and 'Risk of bias' assessments, and disagreements were resolved through discussion with a third review author. Primary outcomes included the mean difference (MD) in reduction of trichotillomania symptoms on a continuous measure of trichotillomania symptom severity, and the risk ratio (RR) of the clinical response based on a dichotomous measure, with 95% confidence intervals (CIs). Main results We identified eight studies with a total of 204 participants and a…

Integrity signals

Registry

Crossref · 10.1002/14651858.cd007662.pub2

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacotherapies including n-acetylcysteine, clomipramine, olanzapine, and dronabinol have indicated efficacious outcomes in trichotillomania, although each has been shown to be efficacious in relatively small samples of clinical trial patients.

    “Pharmacotherapies which have indicated efficacious outcomes in trichotillomania include n-acetylcysteine (NAC), clomipramine, olanzapine, and dronabinol; although, each of these treatments has been shown to be efficacious in relatively small samples of clinical trial patients.”

    From Trichotillomania (hair pulling disorder) (2019) · cites this paper as [34]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rothbart, R., Amos, T., Siegfried, N., Ipser, J. C., Fineberg, N., Chamberlain, S. R., & Stein, D. J.
Affiliations
  • University of British Columbia (CA)
  • University of Cape Town (ZA)
  • Queen Elizabeth II Hospital (GB)
  • University of Cambridge (GB)
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2013-11-08
Volume
9
Issue
11
Pages
CD007662-CD007662
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2085240634
Cited by
106
References
0
Citations by year
2025: 3 · 2024: 3 · 2023: 8 · 2022: 4 · 2021: 14 · 2020: 9 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 11 · 2015: 11 · 2014: 3 · 2013: 1 · 2012: 1
FWCI
1.27
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
Keywords
trichotillomania, pharmacotherapy, olanzapine, N-acetylcysteine, clomipramine, naltrexone, selective serotonin reuptake inhibitors, symptom severity, treatment response, adults, adverse events, attrition bias, risk of bias, obsessive-compulsive spectrum
MeSH terms
Olanzapine, Acetylcysteine, Adult, Benzodiazepines, Clomipramine, Humans, Naltrexone, Trichotillomania, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review